Brief: Gain Therapeutics Files Prospectus For $35.5 Million Stock Sale - SEC Filing
Nov 28 (Reuters) - Gain Therapeutics Inc GANX.O: GAIN THERAPEUTICS INC - FILES PROSPECTUS FOR $35.5 MILLION STOCK SALE - SEC FILING Source text: [ID:n0001104659-25-116947] Further company coverage: GANX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall